{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:42Z","timestamp":1792090002529,"version":"4.4.0"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020M3E5E2036808 2021R1A2C2003629"],"award-info":[{"award-number":["2020M3E5E2036808 2021R1A2C2003629"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The intranasal route has emerged as a promising strategy that can direct delivery of drugs into the systemic circulation because the high-vascularized nasal cavity, among other advantages, avoids the hepatic first-pass metabolism. The nose-to-brain pathway provides a non-invasive alternative to other routes for the delivery of macromolecular therapeutics. A great variety of methodologies has been developed to enhance the efficiency of transepithelial translocation of macromolecules. Among these, the use of cell-penetrating peptides (CPPs), short protein transduction domains (PTDs) that facilitate the intracellular transport of various bioactive molecules, has become an area of extensive research in the intranasal delivery of peptides and proteins either to systemic or to brain compartments. Some CPPs have been applied for the delivery of peptide antidiabetics, including insulin and exendin-4, for treating diabetes and Alzheimer\u2019s disease. This review highlights the current status of CPP-driven intranasal delivery of peptide drugs and its potential applicability as a universal vehicle in the nasal drug delivery.<\/jats:p>","DOI":"10.3389\/fphar.2022.1068495","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T04:32:41Z","timestamp":1668400361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides"],"prefix":"10.3389","volume":"13","author":[{"given":"Jeehye","family":"Maeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunglim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.neuint.2020.104707","article-title":"Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer\u2019s disease","volume":"135","author":"Akhtar","year":"2020","journal-title":"Neurochem. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/10717544.2018.1491653","article-title":"Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin","volume":"25","author":"Bae","year":"","journal-title":"Drug Deliv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1080\/10717544.2019.1628119","article-title":"Optimization of formulation for enhanced intranasal delivery of insulin with translationally controlled tumor protein-derived protein transduction domain","volume":"26","author":"Bae","year":"2019","journal-title":"Drug Deliv."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/10717544.2018.1464081","article-title":"Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin","volume":"25","author":"Bae","year":"","journal-title":"Drug Deliv."},{"key":"B5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jconrel.2013.06.010","article-title":"On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs","volume":"170","author":"Bae","year":"2013","journal-title":"J. Control. Release"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.csbj.2019.09.004","article-title":"Recent advancements in non-invasive formulations for protein drug delivery","volume":"17","author":"Bajracharya","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1096\/fj.12-216176","article-title":"Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis","volume":"27","author":"Bechara","year":"2013","journal-title":"FASEB J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0169-409x(97)00063-x","article-title":"Effects of physicochemical properties and other factors on systemic nasal drug delivery","volume":"29","author":"Behl","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.3390\/pharmaceutics11020073","article-title":"Dual action of the PN159\/KLAL\/MAP peptide: Increase of drug penetration across caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability","volume":"11","author":"Bocsik","year":"2019","journal-title":"Pharmaceutics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"E295","DOI":"10.3390\/molecules23020295","article-title":"Cell penetrating peptides as molecular carriers for anti-cancer agents","volume":"23","author":"Borrelli","year":"2018","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1038\/s41598-017-04409-x","article-title":"A change in the aggregation pathway of bovine serum albumin in the presence of arginine and its derivatives","volume":"7","author":"Borzova","year":"2017","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"14214","DOI":"10.1021\/ja0366989","article-title":"Orientation and conformation of cell-penetrating peptide penetratin in phospholipid vesicle membranes determined by polarized-light spectroscopy","volume":"125","author":"Brattwall","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00115-013-3806-8","article-title":"Targeting the brain through the nose. Effects of intranasally administered insulin","volume":"84","author":"Br\u00fcnner","year":"2013","journal-title":"Nervenarzt"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther. Deliv."},{"key":"B15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jconrel.2014.05.003","article-title":"Chitosan in nasal delivery systems for therapeutic drugs","volume":"190","author":"Casettari","year":"2014","journal-title":"J. Control. Release"},{"key":"B17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2006.10.031","article-title":"The taming of the cell penetrating domain of the HIV tat: Myths and realities","volume":"117","author":"Chauhan","year":"2007","journal-title":"J. Control. Release"},{"key":"B18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2174\/1389201019666180619145429","article-title":"Current therapeutic strategy in the nasal delivery of insulin: Recent advances and future directions","volume":"19","author":"Chen","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1432-1033.2004.04022.x","article-title":"Membrane interaction and cellular internalization of penetratin peptides","volume":"271","author":"Christiaens","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fpsyt.2012.00047","article-title":"Expression of tight junction and drug efflux transporter proteins in an in vitro model of human blood-brain barrier","volume":"3","author":"Cioni","year":"2012","journal-title":"Front. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/pharmaceutics14030629","article-title":"Evaluation of recent intranasal drug delivery systems to the central nervous system","volume":"14","author":"Crowe","year":"2022","journal-title":"Pharmaceutics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u2019s disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"10444","DOI":"10.1016\/s0021-9258(17)34080-2","article-title":"The third helix of the Antennapedia homeodomain translocates through biological membranes","volume":"269","author":"Derossi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: Mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms17020263","article-title":"Intracellular delivery of proteins with cell-penetrating peptides for therapeutic uses in human disease","volume":"17","author":"Dinca","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1038\/nprot.2007.302","article-title":"Assessing the delivery efficacy and internalization route of cell-penetrating peptides","volume":"2","author":"El Andaloussi","year":"2007","journal-title":"Nat. Protoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res. Bull."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejpb.2014.03.004","article-title":"Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules","volume":"88","author":"Fortuna","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/156720112803529828","article-title":"Anatomical and histological factors affecting intranasal drug and vaccine delivery","volume":"9","author":"Gizurarson","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/pharmaceutics14081562","article-title":"Advances in development, characterisation and application of nasal drug delivery systems","volume":"14","author":"Hafner","year":"2022","journal-title":"Pharmaceutics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40263-020-00781-x","article-title":"Intranasal insulin for Alzheimer\u2019s disease","volume":"35","author":"Hallschmid","year":"2021","journal-title":"CNS Drugs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/272827a0","article-title":"Insulin receptors are widely distributed in the central nervous system of the rat","volume":"272","author":"Havrankova","year":"1978","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2165\/00003088-199223010-00003","article-title":"Intranasal insulin. Clinical pharmacokinetics","volume":"23","author":"Illum","year":"1992","journal-title":"Clin. Pharmacokinet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s0168-3659(02)00363-2","article-title":"Nasal drug delivery-possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.88.5.1864","article-title":"Antennapedia homeobox peptide regulates neural morphogenesis","volume":"88","author":"Joliot","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ncb0304-189","article-title":"Transduction peptides: From technology to physiology","volume":"6","author":"Joliot","year":"2004","journal-title":"Nat. Cell. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jps.23364","article-title":"Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps","volume":"102","author":"Kamei","year":"","journal-title":"J. Pharm. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J. Control. Release"},{"key":"B44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2009.02.015","article-title":"Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide\/protein absorption using cell-penetrating peptides","volume":"136","author":"Kamei","year":"2009","journal-title":"J. Control. Release"},{"key":"B45","doi-asserted-by":"publisher","first-page":"17641","DOI":"10.1038\/s41598-018-36210-9","article-title":"Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction","volume":"8","author":"Kamei","year":"2018","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1002\/jps.23708","article-title":"Mechanistic study of the uptake\/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport","volume":"102","author":"Kamei","year":"","journal-title":"J. Pharm. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1021\/acs.molpharmaceut.5b00854","article-title":"Visualization and quantitative assessment of the brain distribution of insulin through nose-to-brain delivery based on the cell-penetrating peptide noncovalent strategy","volume":"13","author":"Kamei","year":"2016","journal-title":"Mol. Pharm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/pharmaceutics13111745","article-title":"Investigation of the transport pathways associated with enhanced brain delivery of peptide drugs by intranasal coadministration with penetratin","volume":"13","author":"Kamei","year":"2021","journal-title":"Pharmaceutics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jconrel.2014.11.004","article-title":"Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides","volume":"197","author":"Kamei","year":"2015","journal-title":"J. Control. Release"},{"key":"B50","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1021\/acs.molpharmaceut.6b01134","article-title":"Effect of an enhanced nose-to-brain delivery of insulin on mild and progressive memory loss in the senescence-accelerated mouse","volume":"14","author":"Kamei","year":"2017","journal-title":"Mol. Pharm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/MDER.S70856","article-title":"Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles","volume":"8","author":"Kanazawa","year":"2015","journal-title":"Med. Devices"},{"key":"B52","doi-asserted-by":"publisher","first-page":"170149","DOI":"10.1016\/j.peptides.2019.170149","article-title":"The rational design of cell-penetrating peptides for application in delivery systems","volume":"121","author":"Kang","year":"2019","journal-title":"Peptides"},{"key":"B53","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1567201816666191029122740","article-title":"Drug delivery and targeting to the brain through nasal route: Mechanisms, applications and challenges","volume":"16","author":"Kashyap","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3109\/21691401.2015.1012260","article-title":"In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane","volume":"44","author":"Kaur","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer\u2019s disease and related disorders: Mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ejpb.2013.09.014","article-title":"One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats","volume":"85","author":"Khafagy","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B57","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jecm.2012.06.013","article-title":"Cell-penetrating peptide-biodrug strategy for oral and nasal delivery: Review of recent findings","volume":"4","author":"Khafagy","year":"2012","journal-title":"J. Exp. Clin. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jconrel.2010.01.019","article-title":"Structural requirements of penetratin absorption enhancement efficiency for insulin delivery","volume":"143","author":"Khafagy","year":"","journal-title":"J. Control. Release"},{"key":"B59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2008.09.076","article-title":"Effect of cell-penetrating peptides on the nasal absorption of insulin","volume":"133","author":"Khafagy","year":"","journal-title":"J. Control. Release"},{"key":"B60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijpharm.2009.07.022","article-title":"Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins","volume":"381","author":"Khafagy","year":"","journal-title":"Int. J. Pharm."},{"key":"B61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijpharm.2009.12.060","article-title":"The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides","volume":"388","author":"Khafagy","year":"","journal-title":"Int. J. Pharm."},{"key":"B62","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1021\/mp500547f","article-title":"Cellular uptake mechanism of TCTP-PTD in human lung carcinoma cells","volume":"12","author":"Kim","year":"2015","journal-title":"Mol. Pharm."},{"key":"B63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biomaterials.2010.08.077","article-title":"A protein transduction domain located at the NH2-terminus of human translationally controlled tumor protein for delivery of active molecules to cells","volume":"32","author":"Kim","year":"","journal-title":"Biomaterials"},{"key":"B64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejps.2011.03.007","article-title":"Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein","volume":"43","author":"Kim","year":"","journal-title":"Eur. J. Pharm. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jconrel.2018.12.023","article-title":"Enhanced intranasal insulin delivery by formulations and tumor protein-derived protein transduction domain as an absorption enhancer","volume":"294","author":"Kim","year":"2019","journal-title":"J. Control. Release"},{"key":"B66","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/bc5005763","article-title":"Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation","volume":"26","author":"Kristensen","year":"","journal-title":"Bioconjug. Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1208\/s12248-015-9747-3","article-title":"Penetratin-mediated transepithelial insulin permeation: Importance of cationic residues and pH for complexation and permeation","volume":"17","author":"Kristensen","year":"","journal-title":"AAPS J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e1178369","DOI":"10.1080\/21688370.2016.1178369","article-title":"Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals","volume":"4","author":"Kristensen","year":"2016","journal-title":"Tissue Barriers"},{"key":"B69","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/14712598.2021.1823368","article-title":"Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics","volume":"21","author":"Kurrikoff","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1021\/mp400680d","article-title":"Strategies to deliver peptide drugs to the brain","volume":"11","author":"Lalatsa","year":"2014","journal-title":"Mol. Pharm."},{"key":"B71","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1517\/17425247.2013.745509","article-title":"Paracellular drug absorption enhancement through tight junction modulation","volume":"10","author":"Lemmer","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"B72","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1529\/biophysj.104.052787","article-title":"Penetratin-membrane association: W48\/R52\/W56 shield the peptide from the aqueous phase","volume":"88","author":"Lensink","year":"2005","journal-title":"Biophys. J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbrc.2005.07.142","article-title":"Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency","volume":"335","author":"Liang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.apsb.2016.04.001","article-title":"Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides","volume":"6","author":"Lin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"B75","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/BJ20030760","article-title":"Passage of cell-penetrating peptides across a human epithelial cell layer in vitro","volume":"377","author":"Lindgren","year":"2004","journal-title":"Biochem. J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ajps.2022.05.002","article-title":"Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers","volume":"17","author":"Liu","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"E598","DOI":"10.3390\/pharmaceutics11110598","article-title":"Perivascular and perineural pathways involved in brain delivery and distribution of drugs after intranasal administration","volume":"11","author":"Lochhead","year":"2019","journal-title":"Pharmaceutics"},{"key":"B78","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1080\/10717544.2022.2122636","article-title":"Protein transduction domain of translationally controlled tumor protein: Characterization and application in drug delivery","volume":"29","author":"Maeng","year":"2022","journal-title":"Drug Deliv."},{"key":"B80","doi-asserted-by":"publisher","first-page":"812387","DOI":"10.1155\/2013\/812387","article-title":"Intranasal, siRNA delivery to the brain by TAT\/MGF tagged PEGylated chitosan nanoparticles","volume":"2013","author":"Malhotra","year":"2013","journal-title":"J. Pharm."},{"key":"B81","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jps.2600760709","article-title":"Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity","volume":"76","author":"McMartin","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/138920101503140822101814","article-title":"Rational design of CPP-based drug delivery systems: Considerations from pharmacokinetics","volume":"15","author":"Mickan","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"B84","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/jfb13030125","article-title":"Biopolymer nanoparticles for nose-to-brain drug delivery: A new promising approach for the treatment of neurological diseases","volume":"13","author":"Montegiove","year":"2022","journal-title":"J. Funct. Biomater."},{"key":"B85","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","article-title":"A novel approach using functional peptides for efficient intestinal absorption of insulin","volume":"118","author":"Morishita","year":"2007","journal-title":"J. Control. Release"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/4042","article-title":"Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration","volume":"4","author":"Nagahara","year":"1998","journal-title":"Nat. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal delivery of high molecular weight drugs","volume":"14","author":"Ozsoy","year":"2009","journal-title":"Molecules"},{"key":"B88","doi-asserted-by":"publisher","first-page":"9051","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: The future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"key":"B89","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/mp800174g","article-title":"Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin","volume":"6","author":"Patel","year":"2009","journal-title":"Mol. Pharm."},{"key":"B90","doi-asserted-by":"publisher","first-page":"288","DOI":"10.18433\/j3nc79","article-title":"Intranasal drug delivery: How, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1021\/jp803640e","article-title":"Adaptation of a membrane-active peptide to heterogeneous environment. I. Structural plasticity of the peptide","volume":"113","author":"Polyansky","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"B92","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2165\/00003088-198917050-00001","article-title":"Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective","volume":"17","author":"Pontiroli","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1042\/BST0350788","article-title":"Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells","volume":"35","author":"Poon","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"B94","doi-asserted-by":"publisher","first-page":"105747","DOI":"10.1016\/j.ejps.2021.105747","article-title":"Short peptide sequence enhances epithelial permeability through interaction with protein kinase C","volume":"160","author":"Ragupathy","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.3390\/ijms22126403","article-title":"Role of insulin in health and disease: An update","volume":"22","author":"Rahman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e3300","DOI":"10.1002\/psc.3300","article-title":"New generation of cell-penetrating peptides: Functionality and potential clinical application","volume":"27","author":"Reissmann","year":"2021","journal-title":"J. Pept. Sci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.2147\/IJN.S183117","article-title":"Liposome delivery systems for the treatment of Alzheimer\u2019s disease","volume":"13","author":"Ross","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"B98","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1021\/bi062309m","article-title":"Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain","volume":"46","author":"Runge","year":"2007","journal-title":"Biochemistry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1021\/bi300454k","article-title":"Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides","volume":"51","author":"Rydberg","year":"2012","journal-title":"Biochemistry"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/a:1018911206646","article-title":"Drug metabolism in the nasal mucosa","volume":"9","author":"Sarkar","year":"1992","journal-title":"Pharm. Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1023\/a:1012160102740","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm. Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: Delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1080\/21691401.2017.1420073","article-title":"Nose to brain transport pathways an overview: Potential of nanostructured lipid carriers in nose to brain targeting","volume":"46","author":"Selvaraj","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","article-title":"Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin","volume":"9","author":"Shan","year":"2015","journal-title":"ACS Nano"},{"key":"B105","doi-asserted-by":"publisher","first-page":"9632","DOI":"10.1523\/JNEUROSCI.2236-04.2004","article-title":"Brain insulin impairs amyloid-beta(1-40) clearance from the brain","volume":"24","author":"Shiiki","year":"2004","journal-title":"J. Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biochi.2014.12.006","article-title":"pH-responsive modulation of insulin aggregation and structural transformation of the aggregates","volume":"109","author":"Smirnova","year":"2015","journal-title":"Biochimie"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer\u2019s disease: Cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J. Exp. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/pharmaceutics14050907","article-title":"Redesigning of cell-penetrating peptides to improve their efficacy as a drug delivery system","volume":"14","author":"Szab\u00f3","year":"2022","journal-title":"Pharmaceutics"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/pharmaceutics14051073","article-title":"Different methods and formulations of drugs and vaccines for nasal administration","volume":"14","author":"Tai","year":"2022","journal-title":"Pharmaceutics"},{"key":"B110","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"B111","first-page":"439","article-title":"Non-invasive strategies for nose-to-brain drug delivery","volume":"10","author":"Trevino","year":"2020","journal-title":"J. Clin. Trials"},{"key":"B112","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.00001.2003","article-title":"Transcytosis: Crossing cellular barriers","volume":"83","author":"Tuma","year":"2003","journal-title":"Physiol. Rev."},{"key":"B113","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1183\/09031936.00212813","article-title":"Medical nanoparticles for next generation drug delivery to the lungs","volume":"44","author":"van Rijt","year":"2014","journal-title":"Eur. Respir. J."},{"key":"B114","doi-asserted-by":"publisher","first-page":"12652","DOI":"10.1021\/bi026097e","article-title":"Evidence for a plasma membrane-mediated permeability barrier to tat basic domain in well-differentiated epithelial cells: Lack of correlation with heparan sulfate","volume":"41","author":"Violini","year":"2002","journal-title":"Biochemistry"},{"key":"B115","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Viv\u00e8s","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: Current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B117","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: From preclinical research to clinical application","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12951-021-01002-3","article-title":"Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: A review","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"21569","DOI":"10.3390\/molecules201219771","article-title":"Amphiphilic lipopeptide-mediated transport of insulin and cell membrane penetration mechanism","volume":"20","author":"Zhang","year":"2015","journal-title":"Molecules"},{"key":"B120","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e822","DOI":"10.1002\/ctm2.822","article-title":"The role of cell-penetrating peptides in potential anti-cancer therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/mp400493b","article-title":"Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery","volume":"11","author":"Zhu","year":"2014","journal-title":"Mol. Pharm."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S0033583522000026","article-title":"Studies of cell-penetrating peptides by biophysical methods","volume":"55","author":"Zorko","year":"2022","journal-title":"Q. Rev. Biophys."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1068495\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T04:32:45Z","timestamp":1668400365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1068495\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":122,"alternative-id":["10.3389\/fphar.2022.1068495"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1068495","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"article-number":"1068495"}}